Publications
Probity Medical Research has compiled journals, articles and presentations for your personal review. Please use the search features below to find an article.
If you would like to request an article for personal review please complete the registration form. These publications are for personal use only and cannot be distributed.
Already granted access to an article?
If you cannot find the article you are looking for please contact Probity Medical Research.
Journals, Articles and Presentations
Articles by Publication Year
Informed Consent, Comparative Effectiveness, and Learning Health Care
The New England Journal of Medicine 2014 Feb;370;8:766-8. DOI: 10.1056/NEJMhle1313674
Informed Consent for Pragmatic Trials — The Integrated Consent Model
The New England Journal of Medicine 2014 Feb 20;370(8):769-72. DOI: 10.1056/NEJMhle1312508.
Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients With Moderate to Severe Psoriasis: 16‐Week Results of a Phase 3, Randomized, Controlled Trial (ESTEEM 2)
Presented at 72nd Annual Meeting of American Academy of Dermatology (AAD) in Denver, Colorado, March 21-25, 2014
Bullous Pemphigoid Associated with Bed Bug (Cimex lectularius) Infestation: A Case Report
Presented at 72nd Annual Meeting of American Academy of Dermatology (AAD) in Denver, Colorado March 21-25, 2014
Collision of Malignant Melanoma and Squamous Cell Carcinoma: A Case Report
Presented at 72nd Annual Meeting of America Academy of Dermatology (AAD) in Denver, Colorado March 21-25, 2014
Efficacy in Relationship With Response to Previous Biologic Psoriasis Therapy: A Subanalysis From the ERASURE Phase 3 Study in Psoriasis
Presented at 72nd Annual Meeting of American Academy of Dermatology (AAD) in Denver, Colorado March 21-25, 2014
Improvement of Psoriasis in Subjects With and Without Psoriatic Arthritis: Subanalysis of a Brodalumab (AMG 827) Phase 2 Study for Moderate to Severe Plaque Psoriasis
Presented at 72nd Annual Meeting of American Academy of Dermatology (AAD) in Denver, Colorado March 21-25, 2014
Safety and efficacy of calcipotriene plus betamethasone dipropionate topical suspension in adolescents with scalp psoriasis: an open, non-controlled, 8-week trial
Presented at 72nd Annual Meeting of American Academy of Dermatology (AAD) in Denver, Colorado March 21-25, 2014
Tildrakizumab (MK-3222), an Anti-IL-23p19 Humanized Monoclonal Antibody, Provides Significant Improvement in Psoriasis Over 52 Weeks of Treatment That Is Maintained After Discontinuation of Dosing
Presented at 72nd Annual Meeting of American Academy of Dermatology (AAD) in Denver, Colorado March 21-25, 2014
The Inflammatory Cascade
Presented at 72nd Annual Meeting of American Academy of Dermatology (AAD) in Denver, Colorado March 21-25, 2014
About PMR | Investigators | Experience | Locations | News | Publications | Privacy Policy | Contact | Sitemap |
Copyright 2014 Probity Medical Research Inc. All Rights Reserved.